00:00And that's a wrap for the financial year, and for Australian stock market investors, it's a mixed bag.
00:05The benchmark S&P ASX200 finished the 12 months up at a less than stellar 2.8%.
00:10Globally, the local burst sharply underperformed its peers.
00:14Wall Street's S&P 500 delivered a massive 19.9% return to investors,
00:18while the global MSCI World Accumulation Index surged over 20%.
00:22Australia was buffeted by stubborn costed living pressures, high interest rates,
00:26and geopolitical shocks from the US-Iran war.
00:29But experts say it wasn't necessarily the total catastrophe many feared.
00:33It all depends on what you owned.
00:35If you're invested in resources, you'll be pleased to hear that the materials sector grew by a massive 48%,
00:40with rare-earth producer Elevra Lithium and gold miner Minerals 260 leading the charge.
00:46The consumer staples sector, which includes companies like Kohl's and Woolies, also increased its value by 10%.
00:51But the ultimate crown goes to biotech firm Forty Medical,
00:54which exploded over 1,700% after securing key US regulatory approval for its lung imaging technology.
01:01But if you were heavy on high-flying growth stocks, it was a pretty brutal year.
01:05The technology and healthcare sectors broadly plunged 37%.
01:09Logistics giant WiseTech Global was the biggest loser of the year,
01:13alongside heavy losses from Xero, 2-As, Cochlea, and CSL.
01:17...
01:20...
01:21...
01:22...
01:23You
Comments